Medicare Enrolled

Dr. Albert Manlapit, MD

Rheumatology · Saginaw, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
5453 HAMPTON PL, Saginaw, MI 48604
9899077636
Registered in NPPES since 2006
NPI: 1205805900 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Manlapit from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manlapit? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Manlapit

Dr. Albert Manlapit is a rheumatology specialist in Saginaw, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Manlapit performed 2,765 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Manlapit received a total of $8,105 from 21 pharmaceutical and/or device companies across 493 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Manlapit is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 29% volume in MI $8,105 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,765
Medicare services
Top 29% in MI for rheumatology
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 672 $16 $42
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
665 $85 $130
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
368 $1 $4
X-ray of hand, 2 views
An X-ray imaging test of the hand using two different angles to visualize the bones and joints.
133 $47 $100
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
84 $48 $137
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
83 $133 $200
Wrist X-ray, 2 views
An X-ray imaging test of the wrist using two different angles to visualize the bones and joints.
82 $49 $120
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
77 $64 $100
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
73 $46 $150
X-ray of foot, 2 views
An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints.
71 $40 $96
New patient office visit, complex (60-74 min) 58 $143 $260
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
54 $98 $250
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
54 $21 $75
Knee X-ray, 1-2 views
An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures.
50 $41 $106
X-ray of both knees, standing
An X-ray image of both knees taken while the patient is standing to assess bone alignment and joint space under weight-bearing conditions.
50 $29 $75
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
50 $69 $90
Shoulder X-ray, 2+ views
An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures.
44 $41 $104
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
33 $9 $60
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
28 $10 $40
X-ray of ankle, 2 views
An X-ray imaging test of the ankle using two different angles to visualize the bones and joints.
25 $41 $110
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
11 $5 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.6% high complexity
45.2% medium
50.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,105
Total received (2018-2024)
Avg $1,158/year across 7 years
Top 28% in MI for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
493
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,441
2023
$1,314
2022
$973
2021
$847
2020
$581
2019
$1,381
2018
$1,567

Payments by company (2024)

ABBVIE INC.
$680
Amgen Inc.
$376
Janssen Biotech, Inc.
$350
Octapharma USA, Inc.
$34
Top 3 companies account for 97.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,910
ABBVIE INC.
$1,586
Janssen Biotech, Inc.
$808
PFIZER INC.
$443
AbbVie Inc.
$412
AbbVie, Inc.
$405
E.R. Squibb & Sons, L.L.C.
$376
Novartis Pharmaceuticals Corporation
$369
Radius Health, Inc.
$234
Merck Sharp & Dohme Corporation
$106
Lilly USA, LLC
$90
Celgene Corporation
$82
GlaxoSmithKline, LLC.
$63
Actelion Pharmaceuticals US, Inc.
$43
Regeneron Healthcare Solutions, Inc.
$38
Octapharma USA, Inc.
$34
GENZYME CORPORATION
$30
Flexion Therapeutics, Inc.
$21
Genentech USA, Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$17
Orthogenrx Inc.
$17
Top 3 companies account for 65.4% of all-time payments
Associated products mentioned in payments ›
ABSOLUTE · BENLYSTA · COSENTYX · EVENITY · Enbrel · FORTEO · GenVisc 850 · HUMIRA · Humira · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Saginaw?
Compare rheumatologists in the Saginaw area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
8
County median income
$58,347
Nearest hospital to ZIP centroid (approximate)
HEALTHSOURCE SAGINAW
4.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Manlapit is a clinical cardiology specialist, with above-average Medicare volume (top 29% in MI), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Manlapit experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Manlapit performed 672 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Manlapit receive payments from pharmaceutical companies?
Yes. Dr. Manlapit received a total of $8,105 from 21 companies across 493 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manlapit's costs compare to other rheumatologists in Saginaw?
Dr. Manlapit's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manlapit) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →